Gritstone Oncology Announces the Addition of Jean-Charles Soria, M.D., Ph.D., to its Scientific Advisory BoardGlobeNewsWire • 06/10/20
Gritstone Oncology (GRTS): Strong Industry, Solid Earnings Estimate RevisionsZacks Investment Research • 05/22/20
Gritstone Oncology Inc (GRTS) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/07/20
Gritstone Oncology Announces the Appointment of Dr. Elaine V. Jones as Chair of the Board of DirectorsGlobeNewsWire • 05/01/20
Gritstone Oncology, Inc. (GRTS) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • 03/11/20
Gritstone Oncology, Inc. (GRTS) Reports Q3 Loss, Misses Revenue EstimatesZacks Investment Research • 11/12/19
Will Gritstone Oncology, Inc. (GRTS) Report Negative Q3 Earnings?Zacks Investment Research • 11/06/19
Gritstone Oncology Announces Data on Novel Shared Tumor-Specific Neoantigens Identified by its EDGE Platform and Contained Within its SLATE ImmunotherapyGlobeNewsWire • 11/05/19
Gritstone Oncology Announces Upcoming Presentation on Novel Shared Neoantigens Included within “Off-The-Shelf” SLATE Immunotherapy at SITC 2019 Annual MeetingGlobeNewsWire • 10/07/19
Gritstone Oncology Announces Changes to its Board of Directors, Including the Appointment of Biotech Veteran Dr. Elaine V. JonesGlobeNewsWire • 09/12/19